NCT03776253Completed
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer
Conquer Fear SUPPORT: A Psychosocial Intervention in Patients With Advanced Cancer
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression. The intervention is adapted from a novel program called "Conquer Fear" which was developed by researchers in Australia. CFS may help in reducing worries, fears, and uncertainty in patients with advanced lung or gynecological cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 39 (actual)
- First submitted
- 31 Oct 2018
- Start date
- 13 Nov 2018
- Primary completion date
- 26 Jul 2024
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT03776253
What you commit to
- Study type: Interventional
- Participants enrolled: 39
- From 13 Nov 2018 to the primary completion date, 26 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are currently receiving ongoing psychiatric treatment
Other illness
- Current severe depression or psychosis; significant cognitive impairment
- Patients enrolled in hospice care or who opt to receive no further disease-focused treatment
Other
- Non-English speaking
Who the study is looking for
- Patients with gynecologic (GYN) and lung cancer will be recruited
- Stage III or IV disease
- At least 3 months from initial diagnosis
- Receiving disease-focused treatment or active surveillance mode
- A score of ≥ 34 on the Fear of Progression Questionnaire-Short Form (SF) or ≥ 24 on the Impact of Event Scale-Revised
- All subjects must have the ability to understand and the willingness to sign a written informed consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.